share_log

UnitedHealth | 8-K: UnitedHealth Group Reports 2023 Results

联合健康 | 8-K:联合健康报告2023年业绩

美股SEC公告 ·  01/12 00:00
Moomoo AI 已提取核心信息
On January 12, 2024, UnitedHealth Group Incorporated released its fourth quarter and full year 2023 financial results. The report highlighted a 15% year-over-year revenue increase to $371.6 billion, with earnings from operations growing by 14%. The company's cash flows from operations were reported at $29.1 billion, equating to 1.3 times the net income. UnitedHealth Group's full year and fourth quarter net earnings per share were $23.86 and $5.83, respectively, with adjusted net earnings per share at $25.12 and $6.16. The results reflected growth across both Optum and UnitedHealthcare, with the company entering 2024 prepared to continue its growth trajectory. The report also mentioned the pending sale of UnitedHealth's Brazil operations, expected to close in the first half of 2024, which will impact net earnings outlook. The company confirmed the...Show More
On January 12, 2024, UnitedHealth Group Incorporated released its fourth quarter and full year 2023 financial results. The report highlighted a 15% year-over-year revenue increase to $371.6 billion, with earnings from operations growing by 14%. The company's cash flows from operations were reported at $29.1 billion, equating to 1.3 times the net income. UnitedHealth Group's full year and fourth quarter net earnings per share were $23.86 and $5.83, respectively, with adjusted net earnings per share at $25.12 and $6.16. The results reflected growth across both Optum and UnitedHealthcare, with the company entering 2024 prepared to continue its growth trajectory. The report also mentioned the pending sale of UnitedHealth's Brazil operations, expected to close in the first half of 2024, which will impact net earnings outlook. The company confirmed the adjusted earnings outlook presented at its Investor Conference. UnitedHealthcare saw a 12.7% increase in full year revenues to $281.4 billion, while Optum's full year revenues grew by 24% to $226.6 billion. The company's medical care ratio and operating cost ratio were also discussed, along with details on customer growth in various segments. UnitedHealth Group's CEO, Andrew Witty, expressed confidence in the company's ability to build on its efforts to improve patient care and consumer experiences.
2024年1月12日,UnitedHealth Group Incorporated发布了其2023年第四季度和全年财务业绩。该报告强调,收入同比增长15%,达到3716亿美元,运营收益增长14%。据报道,该公司的运营现金流为291亿美元,相当于净收入的1.3倍。UnitedHealth Group全年和第四季度的每股净收益分别为23.86美元和5.83美元,调整后的每股净收益为25.12美元和6.16美元。业绩反映了Optum和UnitedHealthcare的增长,该公司进入2024年,准备继续保持其增长轨迹。该报告还提到,UnitedHealth在巴西的业务即将出售,预计将于2024年上...展开全部
2024年1月12日,UnitedHealth Group Incorporated发布了其2023年第四季度和全年财务业绩。该报告强调,收入同比增长15%,达到3716亿美元,运营收益增长14%。据报道,该公司的运营现金流为291亿美元,相当于净收入的1.3倍。UnitedHealth Group全年和第四季度的每股净收益分别为23.86美元和5.83美元,调整后的每股净收益为25.12美元和6.16美元。业绩反映了Optum和UnitedHealthcare的增长,该公司进入2024年,准备继续保持其增长轨迹。该报告还提到,UnitedHealth在巴西的业务即将出售,预计将于2024年上半年结束,这将影响净收益前景。该公司确认了在投资者会议上公布的调整后收益展望。UnitedHealthcare的全年收入增长了12.7%,达到2814亿美元,而Optum的全年收入增长了24%,达到2,266亿美元。还讨论了该公司的医疗保健比率和运营成本比率,以及各细分市场客户增长的细节。UnitedHealth Group首席执行官安德鲁·威蒂表示相信,该公司有能力在改善患者护理和消费者体验的基础上再接再厉。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息